Freestone Capital Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,000
Closed -$5.31M 467
2023
Q4
$5.31M Hold
10,000
0.24% 72
2023
Q3
$5.06M Hold
10,000
0.27% 66
2023
Q2
$5.22M Hold
10,000
0.21% 71
2023
Q1
$5.76M Hold
10,000
0.26% 62
2022
Q4
$5.51M Buy
+10,000
New +$5.3M 0.25% 65

Other funds holding TMO

Freestone Capital Holdings's TMO Position: Q1 2026 in Review

Freestone Capital Holdings reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $195K and leaving 29,810 shares worth $14.7M. The position accounts for 0.44% of the portfolio, ranked #38.

Freestone Capital Holdings first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $17.5M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Freestone Capital Holdings held 29,810 shares of Thermo Fisher Scientific worth $14.7M as of Q1 2026.
  • Freestone Capital Holdings sold 359 Thermo Fisher Scientific shares in Q1 2026, an estimated $195K.
  • Thermo Fisher Scientific made up 0.44% of Freestone Capital Holdings's portfolio in Q1 2026, its #38 holding.
  • Freestone Capital Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
  • Freestone Capital Holdings's Thermo Fisher Scientific position peaked at $17.5M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.